Salerno will participate at the 2022 ascp to promote flolipid (simvastatin)
PRESS RELEASE - October 31st, 2022 at 11:20 pm EDT
Azorian Pharma, LLC and Salerno Pharmaceuticals are pleased to announce their participation in the ASCP Annual Meeting & Exhibition. The event will be held at JW Marriott San Antonio Hill Country in San Antonio, Texas from November 3-6, 2022. Come visit us at booth 308.
The ASCP Annual Meeting is the premier educational and networking event for LTC pharmacy owners/operators, decision-makers, consulting pharmacists, and other professionals specializing in geriatric medication management. ASCP Expo features industry booths, interactive demonstrations, and networking receptions, all designed to maximize attendee engagement.
¹ ASCP is a membership association that represents pharmacists, health care professionals, and students serving the unique medication needs of older adults. ASCP is an international organization with members in all 50 states, Puerto Rico, and 12 countries.
FloLipid™ Oral Suspension (simvastatin) is the first cholesterol medication in liquid form to be provided to U.S. patients. Liquid simvastatin helps reduce the level of LDL cholesterol and triglycerides, while simultaneously increasing HDL cholesterol levels. It also may help lower the risk of stroke, heart attack, and other heart complications from patients at risk due to diabetes and coronary heart disease. FloLipid™ Oral Suspension (simvastatin) is formulated to provide an effective liquid-form alternative for high cholesterol treatment for those who have difficulty swallowing pills.
About AZORIAN Pharma, LLC
Azorian Pharma, LLC is a privately held healthcare company headquartered in Delaware, with operations in Detroit, Michigan, and Los Angeles, California. For further information please visit www.azorianpharma.com.
About Salerno Pharmaceuticals, LLC
Salerno Pharmaceuticals, LLC, is a privately held specialty pharmaceutical company based in Brooksville, FL. For more information, visit www.salernopharma.com.
Contacts:
For Azorian:
Matt V. Phillips
Chief Executive Officer Azorian Pharma, LLC
Office: (650) 516-4310
Email: matt@azorianpharma.com
Salerno® and the Salerno logo are registered trademarks of Salerno Pharmaceuticals, LLC.
FloLipid™ is a trademark of Salerno Pharmaceuticals, LLC.
Azorian® and the Azorian logo are registered trademarks of Azorian Pharma, LLC.
All other trademarks are the property of their respective owners.
© 2022 Azorian Pharma, LLC. All Rights Reserved.
Reference
1. ASCP 2022 Annual Meeting
FloLipid is a prescription medication that should only be taken with supervision by a licensed healthcare professional. Ask your healthcare provider if FloLipid® is right for you.
• Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements
You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Please see the full Product Information for more details:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6ee17d10-6eb1-452a-99e8-02381368b3fe
Source: Azorian Pharma, LLC